Your browser doesn't support javascript.
loading
Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling.
Nagao, Hirofumi; Cai, Weikang; Brandão, Bruna B; Wewer Albrechtsen, Nicolai J; Steger, Martin; Gattu, Arijeet K; Pan, Hui; Dreyfuss, Jonathan M; Wunderlich, F Thomas; Mann, Matthias; Kahn, C Ronald.
Affiliation
  • Nagao H; Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Cai W; Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Brandão BB; Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, USA.
  • Wewer Albrechtsen NJ; Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Steger M; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Gattu AK; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences,and.
  • Pan H; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Dreyfuss JM; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Wunderlich FT; Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Mann M; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Kahn CR; Bioinformatics and Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
J Clin Invest ; 133(4)2023 02 15.
Article de En | MEDLINE | ID: mdl-36548088
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteur à l'insuline / Transduction du signal / Récepteur IGF de type 1 / Insuline Limites: Animals / Humans Langue: En Journal: J Clin Invest Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteur à l'insuline / Transduction du signal / Récepteur IGF de type 1 / Insuline Limites: Animals / Humans Langue: En Journal: J Clin Invest Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique